48 Ken Fisher Abbvie Trades
Ken Fisher's position in Abbvie is currently worth $8.02 Million. That's 0.00% of their equity portfolio (436th largest holding). The first Abbvie trade was made in Q1 2013. Since then Ken Fisher bought shares 22 more times and sold shares on 25 occasions. The stake costed the investor $2.3 Million, netting the investor a gain of 249% so far.
Avg closing price
Price range
Increased shares by 11.1% (+4.32 Thousand shares)
Q4 2024
Avg closing price
$183.81
Price range
$164.95
-
$203.87
Sold 2.2% shares (-885 shares)
Q3 2024
Avg closing price
$186.44
Price range
$163.84
-
$199.35
Increased shares by 17.3% (+5.88 Thousand shares)
Q2 2024
Avg closing price
$165.65
Price range
$154.79
-
$180.76
Increased shares by 0.0% (+14 shares)
Q1 2024
Avg closing price
$172.34
Price range
$159.82
-
$182.10
Sold 8.3% shares (-3.07 Thousand shares)
Q4 2023
Avg closing price
$145.79
Price range
$137.60
-
$154.97
Increased shares by 21.6% (+6.56 Thousand shares)
Q3 2023
Avg closing price
$146.80
Price range
$133.59
-
$154.65
Increased shares by 10.6% (+2.92 Thousand shares)
Q2 2023
Avg closing price
$146.64
Price range
$132.51
-
$164.90
Sold 9.0% shares (-2.71 Thousand shares)
Q1 2023
Avg closing price
$152.88
Price range
$144.61
-
$166.55
Sold 17.3% shares (-6.3 Thousand shares)
Q4 2022
Avg closing price
$153.33
Price range
$138.31
-
$165.99
Increased shares by 2.1% (+751 shares)
Q3 2022
Avg closing price
$143.50
Price range
$134.21
-
$153.93
Increased shares by 6.3% (+2.11 Thousand shares)
Q2 2022
Avg closing price
$152.80
Price range
$137.62
-
$174.96
Sold 9.4% shares (-3.51 Thousand shares)
Q1 2022
Avg closing price
$145.26
Price range
$131.98
-
$163.75
Increased shares by 5.3% (+1.88 Thousand shares)
Q4 2021
Avg closing price
$118.13
Price range
$107.43
-
$135.93
Increased shares by 10.9% (+3.46 Thousand shares)
Q3 2021
Avg closing price
$114.27
Price range
$106.40
-
$120.78
Increased shares by 1.1% (+352 shares)
Q2 2021
Avg closing price
$112.62
Price range
$105.21
-
$117.21
Sold 4.8% shares (-1.6 Thousand shares)
Q1 2021
Avg closing price
$106.96
Price range
$102.30
-
$112.62
Increased shares by 11.4% (+3.38 Thousand shares)
Q4 2020
Avg closing price
$96.10
Price range
$80.49
-
$108.67
Sold 5.5% shares (-1.74 Thousand shares)
Q3 2020
Avg closing price
$94.15
Price range
$85.91
-
$100.83
Increased shares by 10.3% (+2.94 Thousand shares)
Q2 2020
Avg closing price
$88.05
Price range
$73.37
-
$98.18
Sold 90.5% shares (-271 Thousand shares)
Q1 2020
Avg closing price
$85.18
Price range
$64.50
-
$97.79
News about Abbvie Inc and Ken Fisher
Pharmaceutical Contract Development & Manufacturing Market 2020-2027: Size, Share, Growth, Trends with Key Players Analysis- AbbVie, Almac Group, Catalent, Evonik, Lonza, Recipharm AB, Siegfried AG, The Aenova Group, Thermo Fisher Scientific, Vetter etc.
A new market report by The Insight Partners on the Laboratory Informatics Market has been released with reliable information and accurate forecasts for a bet...
e-Pharma Market 2020 Analysis, Size, Share, Growth, Trends And Forecast, Leading Players are AbbVie, Walmart, Giant Eagle, OptumRx, Thermo Fisher Scientific
The winning e-Pharma Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of ...